Investors :: Corporate Governance :: Board of Directors
Board of Directors
Irene Chang Britt is the Chairperson of our board of directors. She served as President, Pepperidge Farm, a subsidiary of Campbell Soup Company from August 2012 to February 2015 and also held the position of Senior Vice President, Global Baking and Snacking for Campbell from March 2012 to February 2015. Ms. Chang Britt joined Campbell in 2005 and held a series of leadership positions with Campbell including Senior Vice President and Chief Strategy Officer and President, North America Foodservice. Ms. Chang Britt is a director of each of Dunkin’ Brands Group, Inc. and Tailored Brands, Inc., and formerly served on the board of directors of Sunoco, Inc. Ms. Chang Britt brings to the Board a deep knowledge of the consumer packaged goods category, and extensive executive experience.
Apu Mody is Chief Executive Officer and a member of the board of directors of TerraVia Holdings, Inc. Mr. Mody brings over 25 years of experience and a strong record of financial success and innovation in the CPG, Retail and Restaurant sectors. Most recently, as President of Mars Food America, he was responsible for a significant turnaround of the business covering the US, Canada, Brazil and the Middle East, eventually creating the fastest growing region for Mars Food. While at Mars, Apu served on the Executive Committee and Board of Directors of the GMA (Grocery Manufacturers of America). Prior to Mars, Apu spent six years at Del Monte Foods, in various Strategy and General Management roles, ultimately joining the Executive team as the SVP and GM for the $2.4B Consumer Products Division where he led the development of a long term vision to focus on healthy eating while creating internal and external alignment for a sustainable platform for growth. Mr. Mody holds an undergraduate degree from the University of Michigan and an M.B.A. with Distinction from the University of Michigan.
Jonathan S. Wolfson is a member of the board and co-founder of TerraVia Holdings, Inc., and co-founded and served as Chief Executive Officer at its predecessor, Solazyme, Inc. He served as Chief Executive Officer of TerraVia until 2016. Prior to TerraVia, Mr. Wolfson was Vice President of Finance and Business Development for 7thOnline, Inc., a supply chain software company. Immediately prior to that he co-founded InvestorTree, a SaaS/Internet based financial services company and was an adjunct faculty member in the Economics department at Hunter College (CUNY). Jonathan has directed TerraVia’s overall strategy and execution since inception, leading Forbes to name him one of the “12 Most Disruptive Names in Business”. The Biotechnology Industry Organization (BIO) named Jonathan the recipient of its 2015 George Washington Carver Award, Biofuels Digest named him the #1 CEO in the top 100 people in the Bioeconomy, Emory University selected him as one of its “history makers”, the Clinton Global Initiative recognized him with its “Green Leap” award and he led TerraVia’s international selection as a World Economic Forum Technology Pioneer.
Mr. Wolfson has been an active participant in advisory groups including the Center for American Progress (CAP) Clean Tech Council and is a member of the board of directors of the Biotechnology Industry Organization (BIO) where he sits on the governing board of the Industrial and Environmental Section. Mr. Wolfson also sits on the supervisory board of Avantium N.V., a renewable chemicals company. Mr. Wolfson obtained a law degree from New York University (NYU) School of Law and an M.B.A. from NYU Stern School of Business. He has served as a member of our board of directors since inception and continues in an active leadership role as Executive Chairman of the Board of Directors.
Michael V. Arbige has been a member of our board of directors since 2005. In May 2011, E.I. du Pont de Nemours and Company acquired Genencor International, Inc., a division of Danisco US Inc., a diversified biotechnology company, and Dr. Arbige was appointed Vice President, Research and Development of the Industrial Biotechnology Division. From 1990 to 2011, Dr. Arbige held a variety of positions at Genencor, most recently as its Executive Vice President of Research and Development, a position he held from 2009 to 2011. He is responsible for all activities associated with managing and driving the research and development activities for the division. Dr. Arbige obtained his Ph.D. in Microbial Physiology and Genetics in 1982 from the University of New Hampshire. Dr. Arbige is a valuable member of the board of directors due to his experience in and knowledge of the biotechnology sector.
Ian T. Clark has been a member of our board of directors since April 2011. Mr. Clark currently serves as chief executive officer of Genentech, Inc., a member of the Roche Group, and head of North American Commercial Operations. He was appointed to this role in January 2010. Mr. Clark also leads the Genentech executive committee and is a member of the Genentech board of directors. Mr. Clark joined Genentech in 2003 as senior vice president and general manager, BioOncology. In August 2005 he was named senior vice president, Commercial Operations and became a member of the executive committee, and in January 2006, he was named executive vice president, Commercial Operations. In April 2009, he was named head of Global Product Strategy and chief marketing officer. Prior to joining Genentech, Mr. Clark served as president of Novartis Canada, overseeing all of the company’s country operations. Before assuming his post in Canada, Mr. Clark served as chief operating officer for Novartis United Kingdom. Prior to joining Novartis in 1999, Mr. Clark worked in vice presidential roles in sales and marketing for Sanofi (Aventis) and Ivax in the United Kingdom and Eastern Europe. Mr. Clark has served on the board of the Biotechnology Industry Organization (BIO) Industry Association since 2009, is an advisor to the Institute of Life Sciences at Southampton University in the United Kingdom, and is a member of the Federal Reserve Bank of San Francisco’s Economic Advisory Council. Mr. Clark received a Bachelor of Science degree in biological sciences from Southampton University in the United Kingdom. Mr. Clark is a valuable member of the board of directors due to his experience in and knowledge of the biotechnology sector and his leadership experience.
James R. Craigie has been a member of the board of directors since 2013. He has been the Chairman of Church & Dwight Co., Inc., a leading developer, manufacturer and marketer of household and personal care consumer packaged goods, since 2007. From June 2007 to December 2015, he was the Chairman and Chief Executive Officer of Church & Dwight, and from July 2004 through May 2007, he was the President and Chief Executive Officer of Church & Dwight. He has served on the board of directors of Church & Dwight since 2004. From December 1998 through September 2003, he was President, Chief Executive Officer and a member of the board of directors of Spalding Sports Worldwide and its successor, Top-Flite Golf Co. During the period from 1983 to November 1998, Mr. Craigie held various senior management positions with Kraft Foods Inc. Prior to entering private industry, he served for six years as an officer in the U.S. Navy/Department of Energy working for Admiral Rickover. He currently serves as a member of the boards of directors of Bloomin’ Brands, Inc., a casual dining company and the Gettysburg Foundation, a non-profit foundation involved with restoring the Gettysburg battlefields. Mr. Craigie holds an undergraduate degree from the University of Rochester and an M.B.A. from Harvard University. Mr. Craigie is a valuable member of the board of directors due to his consumer products and brand building experience, particularly in the food, household and personal care sectors, as well as his leadership experience.
Jerry Fiddler has been a member of our board of directors since 2004. He served as Chairman of our board of directors from 2004 to 2016, and has served as lead director since 2016. From 1981 to 2009 Mr. Fiddler was, at various times, the founder, Chief Executive Officer, Chairman and/or director of Wind River Systems, Inc., a publicly held software company, until it was acquired by Intel Corporation, a semiconductor company. Mr. Fiddler is the principal/CEO of Zygote Ventures, LLC. He serves on a number of private company and non-profit boards. Mr. Fiddler obtained an M.S. from the University of Illinois. Mr. Fiddler is a valuable member of the board of directors due to his leadership and corporate governance experience, his experience as Chief Executive Officer and Chairman of a public company, his service on the boards of directors of other private companies and non-profit entities and his extensive knowledge of the company due to his service on the board of directors since 2004, which brings historic understanding and continuity to the board of directors.
Gary M. Pfeiffer has been a member of our board of directors since 2014. He retired in 2006 as the Senior Vice President and Chief Financial Officer of E.I. du Pont de Nemours and Company. He joined DuPont in 1974, where he held positions of increasing responsibility in finance and international operations, as well as in various DuPont divisions. Mr. Pfeiffer served as Secretary of Finance for the state of Delaware from January through June 2009. Mr. Pfeiffer is a director of Quest Diagnostics Incorporated and InterNAP, Inc. and served as a director of Talbots, Inc. from 2005 to 2012. He is the non-executive Chair of the Board of Directors of Christiana Care Health System, a regional hospital system located in Delaware. Mr. Pfeiffer is a valuable member of the board of directors due to his extensive executive experience, including in corporate finance, accounting, international operations, and strategic planning, with a multinational corporation operating in complex industries.